Real-World Data for Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma: How Does Adherence to the IMbrave150 Trial Inclusion Criteria Impact Prognosis?
Titel:
Real-World Data for Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma: How Does Adherence to the IMbrave150 Trial Inclusion Criteria Impact Prognosis?
Auteur:
Rimini, Margherita Persano, Mara Tada, Toshifumi Suda, Goki Shimose, Shigeo Kudo, Masatoshi Cheon, Jaekyung Finkelmeier, Fabian Lim, Ho Yeong Presa, José Masi, Gianluca Yoo, Changhoon Lonardi, Sara Piscaglia, Fabio Kumada, Takashi Sakamoto, Naoya Iwamoto, Hideki Aoki, Tomoko Chon, Hong Jae Himmelsbach, Vera Pressiani, Tiziana Montes, Margarida Vivaldi, Caterina Soldà , Caterina Hiraoka, Atsushi Sho, Takuya Niizeki, Takashi Nishida, Naoshi Steup, Christoph Hirooka, Masashi Kariyama, Kazuya Tani, Joji Atsukawa, Masanori Takaguchi, Koichi Itobayashi, Ei Fukunishi, Shinya Tsuji, Kunihiko Ishikawa, Toru Tajiri, Kazuto Ochi, Hironori Yasuda, Satoshi Toyoda, Hidenori Ogawa, Chikara Nishimura, Takashi Hatanaka, Takeshi Kakizaki, Satoru Shimada, Noritomo Kawata, Kazuhito Tada, Fujimasa Ohama, Hideko Nouso, Kazuhiro Morishita, Asahiro Tsutsui, Akemi Nagano, Takuya Itokawa, Norio Okubo, Tomomi Arai, Taeang Imai, Michitaka Kosaka, Hisashi Naganuma, Atsushi Koizumi, Yohei Nakamura, Shinichiro Kaibori, Masaki Iijima, Hiroko Hiasa, Yoichi Burgio, Valentina Rimassa, Lorenza Scartozzi, Mario Cascinu, Stefano Casadei-Gardini, Andrea
Verschenen in:
Targeted oncology
Paginering:
Jaargang 18 () nr. 2 pagina's 221-233
Jaar:
2023-03-15
Inhoud:
Uitgever:
Springer International Publishing, Cham
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften